---
title: "Product Requirements Document (PRD)"
version: "1.0"
status: "Draft"
owner: "Product Management"
created: "2025-11-27"
updated: "2025-11-27"
project: "Medication Adherence Platform"
---

# Product Requirements Document (PRD)

## 1. Overview & Purpose
This document defines the functional scope and experience expectations for the Medication Adherence Platform. The solution translates the strategic need—improving patient adherence and reducing avoidable complications—into clear product requirements for design, engineering, and clinical stakeholders.

The PRD establishes shared expectations, guides early discovery, and supports delivery of a minimum viable but clinically meaningful product.

---

## 2. Background & Context
Non-adherence drives poor surgical outcomes, chronic disease exacerbations, and significant avoidable cost. The absence of real-time adherence data in clinical workflows limits the ability of providers to intervene proactively.

This platform is designed for rapid pilot deployment with health systems striving to improve quality scores, reduce readmissions, and strengthen post-operative engagement. Initial discovery interviews confirmed strong demand for:
- Structured guidance and reminders for patients  
- A consolidated clinical view of adherence  
- Actionable alerts for early intervention  
- Simple configuration and low integration overhead  

---

## 3. Goals & Non-Goals
### **Goals**
- Provide patients with clear, timely medication reminders and check-ins.  
- Deliver clinicians a consolidated adherence view surfaced in their existing tools.  
- Detect early signs of non-adherence and route them for follow-up.  
- Improve patient outcomes through better visibility and proactive engagement.  
- Demonstrate measurable improvements in pilot populations.

### **Non-Goals**
- Full pharmacy integration (future phase).  
- Automated clinical decision-making beyond informational alerts.  
- Complex AI-driven personalization in the initial release.  
- Multi-language support at launch (English-only for v1).

---

## 4. User Personas & Use Cases
### **Primary Persona: Patient**
- Needs clarity about medication timing, dosage, and purpose.  
- May be overwhelmed during recovery and needs simple, guided interactions.  
**Use Cases:**  
- Receive scheduled reminders.  
- Confirm medication taken ("check-in").  
- View what’s coming next.  
- Ask for help or report concerns.

### **Secondary Persona: Clinician**
- Needs visibility into adherence patterns and risk signals.  
**Use Cases:**  
- View a per-patient adherence summary.  
- Identify patients with missing doses.  
- Initiate follow-up where needed.

### **Care Coordinator**
**Use Cases:**  
- Receive and triage non-adherence alerts.  
- Provide outreach or education.  
- Document follow-up actions.

---

## 5. Functional Requirements

### **FR1 — Patient Medication Schedule Display**
The system must present a clear, daily schedule of required medications, including dosage, timing, purpose, and instructions.

### **FR2 — Reminders & Notifications**
Patients receive push notifications or SMS reminders when it’s time to take a medication.  
- Must support configurable schedules.  
- Must support snooze or “remind me again.”

### **FR3 — Check-In Workflow**
Patients can confirm completion of a medication dose with a single tap.  
- Check-ins update adherence records in real time.  
- Late or missed check-ins generate risk signals.

### **FR4 — Escalation Logic**
The system identifies missed or delayed doses and automatically routes signals to coordinating staff.  
- Thresholds configurable per organization.  
- High-severity alerts require explicit acknowledgment.

### **FR5 — Clinician Dashboard / Panel**
Provides a summarized adherence view showing:  
- % adherence over time  
- Missed doses  
- Trend indicators  
- Patients requiring attention  

### **FR6 — Administrative Configuration**
Admins must be able to:  
- Define medication plans  
- Configure escalation rules  
- Manage user accounts and permissions  

---

## 6. User Experience Considerations
- The patient UI prioritizes clarity, simplicity, and minimal cognitive load.  
- Reminders use supportive, non-alarming language.  
- The interface must be usable by older adults and low digital literacy users.  
- Clinical UI uses concise summaries rather than complex visualizations.

---

## 7. Technical Considerations
- Support FHIR-based integration for fetching medication schedules (where available).  
- Data must sync reliably with EHR systems without requiring deep workflow changes.  
- All PHI must meet HIPAA and organizational compliance requirements.  
- System reliability must support notification delivery within ±5 minutes of scheduled times.

---

## 8. Data Requirements
- Medication data (name, dosage, instructions, schedule)  
- Adherence events (timestamp, status, medication)  
- User engagement data (notification delivery, open rates)  
- Escalation event logs  
- Audit logs for all clinical interactions  

Data must be retained per customer-defined policies (minimum 6 years recommended for healthcare).

---

## 9. Edge Cases & Error Handling
- Missed reminders due to device offline state.  
- Duplicate check-ins.  
- Medication changes mid-cycle.  
- Patient temporarily unable to take medication (e.g., nausea, side effects).  
- Incorrect schedule due to EHR sync errors.

The system should guide the user and surface clear next steps when errors occur.

---

## 10. Dependencies & External Factors
- EHR integration for medication data (FHIR MedicationStatement / MedicationRequest).  
- Patient authentication and identity management systems.  
- Notification infrastructure (APNs, FCM, SMS provider).  
- Availability of care coordinators for escalations.

---

## 11. Rollout Strategy
- Start with a post-operative pilot population from a partner health system.  
- Collect baseline adherence metrics for comparison.  
- Gradually expand to additional surgical specialties.  
- Evaluate configuration needs for chronic care expansion.

---

## 12. Measurement & Success Metrics
- Adherence rate improvement from baseline to 30/60/90 days.  
- Reduction in medication-related complications and readmissions.  
- Percentage of high-severity alerts resolved within targeted time.  
- Patient check-in completion rate.  
- Clinician engagement with adherence dashboards.

---

## 13. Open Questions
- Should we expand to pharmacy refill tracking in early phases?  
- What level of AI-driven risk prediction is desired for v1?  
- Do clinicians prefer an embedded EHR view or standalone dashboard for phase one?  
- What level of reporting is required for quality programs (e.g., CMS measures)?

---

## 14. Appendices
- Early concept sketches  
- Competitive landscape summary  
- Draft medication schedule data model  
- Patient interview highlights  

---